In recognition of members who have contributed significantly to the field, this year TTS is recognizing as “Living Legends” members with extraordinary reputations that have contributed tremendously to the field either through research, innovation or mentorship.
Register to the Congress
Online In-Person registration is closed (You can still register in-person onsite from 2-6 pm on September 10 or after 7 am on September 11).
Virtual Registration will remain open during the entire duration of the congress.
Moving Toward Transplant Tolerance: Is Targeting Donor Antigen-presenting Cells the Key?Donor-specific tolerance is a long-held, elusive goal for transplantation. While robust dominant tolerance across major histocompatibility complex (MHC) barriers has been achieved by numerous manipulations in rodents, translation into nonhuman primate (NHP) models or clinical practice has been challenging. Apart from the induction of hematopoietic chimerism there are very few examples of allograft tolerance in clinical practice. Whether persistent chimerism (versus that of a transient nature) is an absolute requirement for tolerance has been debated, however without resolution. Furthermore, the induction of chimerism requires extensive preconditioning and is associated with significant toxicity, particularly graft versus host disease, factors which have limited its clinical feasibility.
The Role of Donor Sex in Females Undergoing Repeat Kidney Transplant: Does Prior Donor Sex Matter?Female recipients of male donor kidneys are at increased risk for graft failure because of the HY antigen effect. However, whether prior transplant with a male donor impacts subsequent transplant outcomes is unknown. Therefore, the purpose of this study was to determine whether prior male-current male donor sex is associated with an increased risk of graft failure in female recipients.
|Session 1: Qualifying a composite surrogate for long-term graft loss after kidney transplantation
|Session 2: RWE use in transplant clinical trials
|Session 3: Future endpoints in kidney transplantation
This survey focuses on issues encountered by physicians in day-to-day decision-making.
Your responses will aid TTS in developing strategies, programs and resources to improve access and transparency in transplantation, emphasizing increasing deceased donor organ transplantation.
The information collected will also aid the work TTS is doing as part of our World Health Organization collaboration.
All responses will be kept confidential and anonymous.
The Transplantation Society
740 Notre-Dame Ouest
Montréal, QC, H3C 3X6